3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Central Nervous System Neoplasms
2
Thrombocytopenia
1
Testicular Neoplasms
1
Teratoma
1
Stomach Neoplasms
1
Sarcoma
1
Peritoneal Neoplasms
1
Ovarian Neoplasms
1
Ovarian Germ Cell Cancer
1
Ototoxicity
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Mouth Neoplasms
1
Mesothelioma, Malignant
1
Medulloblastoma
1
Lymphoma
1
Liver Neoplasms
1
Laryngeal Neoplasms
1
Intraocular Lymphoma
1
Hypopharyngeal Neoplasms
1
Hyperthermia
1
Hepatoblastoma
1
Gastrointestinal Neoplasms
1
Drug-Related Side Effects and Adverse Reactions
1
Carcinoma
1
Brain Neoplasms
1
Adrenocortical Carcinoma
1
Adenocarcinoma
1
Interventions
Temozolomide
14
Bevacizumab
11
Erlotinib Hydrochloride
5
Radiotherapy
4
Carboplatin
4
Magnetic Resonance Spectroscopy
3
Irinotecan
3
Immunoglobulin G
3
Disulfides
3
temsirolimus
2
poly ICLC
2
palbociclib
2
etoposide phosphate
2
antineoplaston AS 2-1
2
antineoplaston A10
2
Vincristine
2
Sunitinib
2
Sirolimus
2
Everolimus
2
Dasatinib
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
veliparib
1
varlilumab
1
vandetanib
1
trebananib
1
trametinib
1
terameprocol
1
tandutinib
1
selinexor
1
romidepsin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Oligodendroglioma
×
sodium thiosulfate
×
Clear all
No trials found.